NR 603 Week 3 Quiz Possible Questions And Answers

Document Content and Description Below

NR 603 Week 3 Quiz Possible Questions And Answers Question: Per 2013 ACC/AHA guidelines, which patient below would NOT benefit from statin therapy? Question: Which of the following patients shou... ld be on high-intensity statin therapy, if tolerated? Question: For someone who is intolerant to higher doses of statins, has tried 2-3 statins...what do we recommend? Question: You have a patient with ASCVD but no comorbidities. Their LDL has gone down 30% from baseline and they are on maximally tolerated statin therapy. Is this patient appropriate for non-statin therapy and if so, what do you recommend? Question: IG is a 47 yo male with CAD s/p MI 2015. He is currently prescribed atorvastatin 20 mg/day. Pt states he is unable to tolerate higher doses and refuses to try another statin. LDL 114 mg/dL. What is the next best step? Question: YZ is a 67 yo female with DM and 10 year risk score 11.1%. She is currently prescribed atorvastatin 80 mg once daily with reported adherence. Current LDL-C 141 mg/dL. What is the next best step for cardiovascular risk reduction. Question: TL is a 52 yo black male overbooked in your clinic today for evaluation of fasting labs per primary provider request. He is without complaints. Pertinent medications include amlodipine 10 mg/day and atorvastatin 20 mg/day + tobacco use, 3-4 beer/night Labs: TC 302, HDL 21, TG 1167, direct LDL 152, SCr 1.1 BP 145/78, height 74 inches, weight 113.4 kg Question: Which of the following drugs inhibits factor IIa (thrombin) and factor Xa by activating antithrombin? [Show More]

Last updated: 1 year ago

Preview 1 out of 5 pages